IPR Filings on Sustained Upward Trajectory

A recent report from patent data powerhouse RPX Corp. shows that inter partes review (IPR) filings have increased significantly over the last three quarters, pointing to increased litigation over the last year. One possible driving factor? Non-practicing entity litigation, which increased by 24% in Q1 2024 alone, according to RPX. As noted in �鶹ֱ��’s recent PTAB Year in Review, 2024 promises to be a year filled with exciting developments at the PTAB, and the substantial increase in IPR filings will be a further catalyst for change.

The Patent Trial and Appeal Board (PTAB) saw 328 petitions for America Invents Act (AIA) review in the first quarter of 2024, including 322 petitions for inter partes review (IPR) and six petitions for post-grant review (PGR). Filings were down by 5% compared to Q1 2023, which saw 345 petitions filed; but were up by 18% compared to Q4, during which 278 petitions were filed.

[email protected]

Chicago 312.832.4530

Related Insights

August 18, 2026 PTAB Trial Insights

Navigating IPR Discretionary Denial White Waters with Examiner Error: A Practitioner's Guide

Decided five years before the surge of discretionary denial decisions in 2025, the second prong of Advanced Bionics requires the Director to determine “whether the petitioner has demonstrated that the Office erred in a manner material to the patentability of challenged claims” when the same or substantially the same art or arguments previously were presented to the Office.

August 17, 2026 �鶹ֱ�� Viewpoints

Recent SAT Publications on Fraudulent CFDIs – Immediate Risks for Your Business

The Tax Administration Service (SAT) continues to audit taxpayers as part of the new expedited domiciliary audit procedure, through which it can determine whether the digital tax invoices (CFDI) issued by such taxpayers are fraudulent.

August 17, 2026 Health Care Law Today

FQHCs: The Expanding Landscape of Medicare Billing Outside of PPS for Care Management Services

Federally Qualified Health Centers (FQHCs) are primarily reimbursed by Medicare through the Prospective Payment System (PPS), which pays a per-visit rate to cover a typical bundle of medically necessary services provided during a patient encounter. Increasingly, however, FQHCs have opportunities to bill certain care management services to Medicare outside the PPS bundle. The steady expansion of these services over the last decade is one of the most significant changes to Medicare FQHC reimbursement since the Affordable Care Act (ACA).

�鶹ֱ��

Popular Searches